Otsuka Pharmaceutical Development & Commercialization, Inc.

NJ · United States · Reporting entity ID 100000010725

Total reported 2019–2025

$226.5M

#54 of 2,960 reporting companies — 0.3% of all reported industry payments

$24.9M in general payments across 22,701 records, plus $201.6M in research funding across 6,669 records.

How it breaks down

General payments $24,913,616

Research funding $201,627,720

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.